The emergence of community-associated methicillin-resistant S. aureus was associated with dramatically increased skin and soft tissue infection (SSTI) incidence in the first few years of the 21st century in the U.S. However, subsequent trends are poorly understood. Miller et al. (2015) examined ambulatory and inpatient data of more than 48 million persons years aged 0-64 years from the HealthCore Integrated Research Database (HIRD) between 2005 and 2010. Data were extracted from medical, pharmacy and eligibility databases. The researchers quantified SSTI incidence, type and complications and comparative incidence trends for urinary tract infections (UTIs) and pneumonia.
A total of 2,301,803 SSTIs were identified. Most SSTIs (95 percent) were treated in the ambulatory setting and most (60 percent) were categorized as abscesses or cellulitis. During the study period, SSTI incidence remained relatively stable from 47.9 (95% CI: 47.8–48.1) cases/1,000 PY in 2005 to 48.5 cases/1,000 PY (95% CI: 48.3–48.6) in 2010). Persons aged 45-64 years had the highest incidence of both ambulatory-treated and inpatient-treated SSTIs (51.2 (95% CI: 51.1–51.3) and 3.87 (95% CI: 3.84–3.90) cases/1,000 PY, respectively). SSTI complications such as myositis, gangrene, and sepsis occurred in 0.93% (95 % CI: 0.92–0.94%) and 16.92 % (95% CI: 16.87–16.97%) of ambulatory-treated and inpatient-treated patients, respectively. SSTI incidence was approximately twice that of UTIs and tenfold of that of pneumonia.
The researchers conclude that among the study's arge, diverse population of persons less than 65 years, SSTI incidence 2005 through 2010 has remained relatively constant at approximately 4.8 SSTIs per 100 person years, suggesting that previously observed increases in SSTI incidence remain sustained. Their research was published in BMC Infectious Diseases.
Reference: Miller LG, Eisenberg DF, Liu H, Chang CL, Wang Y, Luthra R, Wallace A, Fang C, Singer J and Suaya JA. Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005–2010. BMC Infectious Diseases 2015, 15:362 doi:10.1186/s12879-015-1071-0
Canada Faces Rising Measles Cases: Public Health Urges Vaccination Amid Growing Threat
March 6th 2025Measles cases in Canada are rising, with 227 infections reported in early 2025. Public health officials urge vaccination to prevent outbreaks, severe complications, and further community transmission.
Surging Whooping Cough Cases Highlight the Importance of Vaccination
March 6th 2025Experts like Michael Glazier, MD, warn that waning immunity, declining vaccination rates, and increased transmission are driving this resurgence. Vaccination remains the best defense, with pediatricians urging timely immunization to protect vulnerable populations and prevent further outbreaks.
Measles Outbreak Sparks APIC’s Urgent Call for Stronger Vaccine Policies
March 4th 2025The recent measles-related death in Texas has reignited fears about the consequences of declining vaccination rates and misinformation. Once declared eliminated in the US, measles is resurging with over 150 cases and climbing. APIC warns: this crisis is preventable—but only if we act now.